Affordable Access

Repaglinide induced acute hepototoxicity.

Authors
  • Jaiswal, S
  • Mehta, R
  • Musuku, M
  • Tran, L
  • McNamee, W Jr
Type
Published Article
Journal
JNMA; journal of the Nepal Medical Association
Publication Date
Jan 01, 2009
Volume
48
Issue
174
Pages
162–164
Identifiers
PMID: 20387361
Source
Medline
License
Unknown

Abstract

Repaglinide is considered a safe drug; adverse events are mild to moderate which includes hypoglycemia, headache, nausea, vomiting, diarrhea and dyspepsia as similar to sulphonylureas. This case report describes a rare side effect of repaglinide. In rare cases, elevated liver enzymes have been noted. We report a case of acute hepatotoxicity in a 78-year-old woman who developed acute hepatotoxicity while taking repaglinide.

Report this publication

Statistics

Seen <100 times